Financial Personal
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies, is pl
For more information, please contact: Read More
